---
figid: PMC6977568__i1947-6094-15-4-250-f01
figlink: pmc/articles/PMC6977568/figure/i1947-6094-15-4-250-f01/
number: Figure 1
caption: 'HER2 signaling pathways in cancer cell and cardiac myocyte. (A) In cancer
  cells, the HER2 signaling pathway is activated via different mechanisms. Trastuzumab
  and lapatinib block HER2 signaling at different levels. (B) In cardiac myocytes,
  HER2 signaling is involved in pro-survival pathways, which can be blocked by HER2-targeted
  therapies. HER2: human epidermal receptor 2; ErbB4: erythroblastic leukemia viral
  oncogene B receptors; NRG-1: neuregulin-1 ligand; TK: tyrosine kinase; MAP-RAS-ERK:
  mitogen-activated protein kinase-rate sarcoma virus oncogene-extracellular signal-regulated
  kinase; PI3K-AKT: phosphatidylinositol 3-kinase-protein kinase B; JAK-STAT: Janus
  kinase-signal transducer and activator of transcription protein; Top-2B: topoisomerase-2
  beta isoform; DOX: doxorubicin; ROS: reactive oxygen species'
pmcid: PMC6977568
papertitle: Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies.
reftext: Tolulope A. Agunbiade, et al. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):250-257.
pmc_ranked_result_index: '13167'
pathway_score: 0.652575
filename: i1947-6094-15-4-250-f01.jpg
figtitle: HER2 signaling pathways in cancer cell and cardiac myocyte
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6977568__i1947-6094-15-4-250-f01.html
  '@type': Dataset
  description: 'HER2 signaling pathways in cancer cell and cardiac myocyte. (A) In
    cancer cells, the HER2 signaling pathway is activated via different mechanisms.
    Trastuzumab and lapatinib block HER2 signaling at different levels. (B) In cardiac
    myocytes, HER2 signaling is involved in pro-survival pathways, which can be blocked
    by HER2-targeted therapies. HER2: human epidermal receptor 2; ErbB4: erythroblastic
    leukemia viral oncogene B receptors; NRG-1: neuregulin-1 ligand; TK: tyrosine
    kinase; MAP-RAS-ERK: mitogen-activated protein kinase-rate sarcoma virus oncogene-extracellular
    signal-regulated kinase; PI3K-AKT: phosphatidylinositol 3-kinase-protein kinase
    B; JAK-STAT: Janus kinase-signal transducer and activator of transcription protein;
    Top-2B: topoisomerase-2 beta isoform; DOX: doxorubicin; ROS: reactive oxygen species'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRG1
  - ERBB2
  - TOP2B
  - EGFR
  - ERBB3
  - ERBB4
  - PER2
  - Lapatinib
  - DOX
  - ATP
  - cancer
  - Hypertrophy
genes:
- word: NRG-1
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: NRG-1
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: NRG-1
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: NRG-1
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: TOP2B
  symbol: TOP2B
  source: hgnc_symbol
  hgnc_symbol: TOP2B
  entrez: '7155'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PER2
  symbol: PER2
  source: hgnc_symbol
  hgnc_symbol: PER2
  entrez: '8864'
- word: HER2
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
chemicals:
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: DOX
  source: MESH
  identifier: D004317
- word: ATP
  source: MESH
  identifier: D000255
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: Hypertrophy
  source: MESH
  identifier: D006984
---
